科伦药业：第三季度净利润2亿元 同比下降70.18%

Core Viewpoint - Kolun Pharmaceutical (002422) reported a significant decline in both revenue and net profit for the third quarter of 2025, indicating potential challenges in its financial performance [1] Financial Performance - The company's third-quarter revenue was 4.193 billion yuan, a year-on-year decrease of 15.48% [1] - Net profit for the third quarter was 200 million yuan, down 70.18% year-on-year [1] - For the first three quarters of 2025, total revenue reached 13.277 billion yuan, reflecting a 20.92% decline compared to the previous year [1] - Net profit for the first three quarters was 1.201 billion yuan, which is a 51.41% decrease year-on-year [1] - Basic earnings per share stood at 0.75 yuan [1]